Protein factors can regulate gene expression by binding to specifically modified DNA-associated proteins. Small molecules that selectively interfere with such interaction may be of therapeutic value. See Article p.1067 & Letter p.1119
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cytotoxic activity of bromodomain inhibitor NVS-CECR2-1 on human cancer cells
Scientific Reports Open Access 01 October 2020
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Filippakopoulos, P. et al. Nature 468, 1067–1073 (2010).
Nicodeme, E. et al. Nature 468, 1119–1123 (2010).
Gershey, E. L., Vidali, G. & Allfrey, V. G. J. Biol. Chem. 243, 5018–5022 (1968).
Choudhary, C. et al. Science 325, 834–840 (2009).
Taverna, S. D., Li, H., Ruthenburg, A. J., Allis, C. D. & Patel, D. J. Nature Struct. Mol. Biol. 14, 1025–1040 (2007).
Cole, P. A. Nature Chem. Biol. 4, 590–597 (2008).
Lemoine, M. & Younes, A. Discov. Med. 10, 462–470 (2010).
Wells, J. A. & McClendon, C. L. Nature 450, 1001–1009 (2007).
Sachchidanand et al. Chem. Biol. 13, 81–90 (2006).
Morinière, J. et al. Nature 461, 664–668 (2009).
Reynoird, N. et al. EMBO J. 29, 2943–2952 (2010).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taverna, S., Cole, P. Reader's block. Nature 468, 1050–1051 (2010). https://doi.org/10.1038/4681050a
Published:
Issue Date:
DOI: https://doi.org/10.1038/4681050a
This article is cited by
-
Cytotoxic activity of bromodomain inhibitor NVS-CECR2-1 on human cancer cells
Scientific Reports (2020)
